NEURAXIS, INC. Warrants Not Settleable in Cash, Fair Value Disclosure
NEURAXIS, INC. (NRXS) had Warrants Not Settleable in Cash, Fair Value Disclosure of $2.45 million as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Notes
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2024-04-16
- 2023-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $2.45M.
- 2023-09-30: Warrants Not Settleable in Cash, Fair Value Disclosure $5.25M.
- 2023-06-30: Warrants Not Settleable in Cash, Fair Value Disclosure $4.69M.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2023-12-31 | $2.45M 10-K · filed 2024-04-16 |
| 2023-09-30 | $5.25M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $4.69M 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |